Activating mutation in MET oncogene in familial colorectal cancer.
about
Understanding and Targeting MET Signaling in Solid Tumors - Are We There Yet?Epigenetic Biomarkers in Colorectal Cancer.Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessmentOncogenic codon 13 NRAS mutation in a primary mesenchymal brain neoplasm and nevus of a child with neurocutaneous melanosis.Functional consequence of the MET-T1010I polymorphism in breast cancerExpanding the genotype-phenotype spectrum in hereditary colorectal cancer by gene panel testing.Regulation of the MET oncogene: molecular mechanisms.Hepatocyte Growth Factor, a Key Tumor-Promoting Factor in the Tumor Microenvironment.MET gene copy number alterations and expression of MET and hepatocyte growth factor are potential biomarkers in angiosarcomas and undifferentiated pleomorphic sarcomas.MET in human cancer: germline and somatic mutations.Expanding the spectrum of germline variants in cancer.MET T992I mutation in a case of ependymoblastoma/embryonal tumour with multilayered rosettes.Molecular characterization of oral squamous cell carcinoma using targeted next-generation sequencing.Unexpected cancer-predisposition gene variants in Cowden syndrome and Bannayan-Riley-Ruvalcaba syndrome patients without underlying germline PTEN mutations.Single-nucleotide polymorphism rs41736 located in MET was significantly associated with prognosis of small cell lung cancer patients.
P2860
Q26748581-332C9207-074F-458E-A33F-2F47C1AE8D6FQ30240778-1DAFFF4E-ECE2-4ECD-BD40-F944506F3963Q33796155-7F183333-166E-41B1-AB00-8A9657151A15Q34402363-A9A921CA-1588-4C9D-B838-F238EF5D02C9Q35550045-8CD51073-D69C-48E0-9D7F-58E34D77D7A0Q37710155-45485BA0-85D8-43C8-AF43-4F6028F77B65Q38746401-318C7581-E9BA-4D47-8B68-86AECE1C8A1FQ38831784-D61BFEE7-3263-49D8-A933-FEE40D4AF76AQ39286355-EC363E97-D77C-44F7-BC12-EAE070F2FFC4Q39365962-CAF320F2-EAB0-43F5-9F83-A2E5BA304837Q47567905-21C27A3C-C9E5-48AF-B1EE-D81054BF07B0Q48561269-690FAF03-E049-4BBF-A348-5ABEEED5CC5AQ50440575-AE762CA2-C4B7-4443-94A2-7893A996D061Q52312700-1AE9A064-394D-401D-A67A-9634E8F254B0Q55070113-76A3C0A2-A33E-4AC9-A3FA-D097A21B9BE2
P2860
Activating mutation in MET oncogene in familial colorectal cancer.
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Activating mutation in MET oncogene in familial colorectal cancer.
@ast
Activating mutation in MET oncogene in familial colorectal cancer.
@en
Activating mutation in MET oncogene in familial colorectal cancer.
@nl
type
label
Activating mutation in MET oncogene in familial colorectal cancer.
@ast
Activating mutation in MET oncogene in familial colorectal cancer.
@en
Activating mutation in MET oncogene in familial colorectal cancer.
@nl
prefLabel
Activating mutation in MET oncogene in familial colorectal cancer.
@ast
Activating mutation in MET oncogene in familial colorectal cancer.
@en
Activating mutation in MET oncogene in familial colorectal cancer.
@nl
P2093
P2860
P356
P1433
P1476
Activating mutation in MET oncogene in familial colorectal cancer.
@en
P2093
Alexander R Miller
Ann G Schwartz
Constance A Griffin
Deborah W Neklason
Dennis J Ahnen
Gail E Tomlinson
Jill E Stopfer
Louise C Strong
Michelle W Done
Nykole R Sargent
P2860
P2888
P356
10.1186/1471-2407-11-424
P407
P577
2011-10-04T00:00:00Z
P5875
P6179
1019402369